| |
OREGON CENTER FOR COMPLEMENTARY AND ALTERNATIVE MEDICINE IN NEUROLOGICAL DISORDERS
Dementias
Alzheimer's Association
National Institutes
of Health - National Institute on Aging
Oregon
Alzheimer's Disease Center
Articles:
Kanowski S. Ginkgo-biloba-spezialextrakt;
ein nootropikum mit nachgewiesener wirksamkeit
im indigkationsbereich demenz. [Ginkgo biloba
special extract; a demonstrably effective nootropic
agent in dementia]. Munchener Medizinische Wochenschrift.
1997;139(4): pp. 47-50.
Kanowski S, Hermann WM, Stephan K, et al. Proof of
Efficacy of the Ginkgo Biloba Special Extract EGb 761 in Outpatients
Suffering from Mild to Moderate Primary Degenerative
Dementia of the Alzheimer Type or Multi-infarct
Dementia. Pharmacopsychiatry 1996;29: pp. 47-56.
Le Bars PL, Katz MM, Berman N, et al. A Placebo-controlled,
Double-blind, Randomized Trial of An Extract of Ginkgo Biloba for
Dementia. The Journal of the American Medical Association. 1997;278: pp. 1327-1332.
Le Bars PL, Kieser M, Itil KZ. A 26-Week Analysis of a Double-Blind, Placebo-Controlled
Trial of the Gingko Biloba Extract EGb 761 in Dementia. Dementia and Geriatric Cognitive Disorders. 2000;
11: pp. 230-237.
Oken BS, Storzbach DM, Kaye JA. The Efficacy of Ginkgo Biloba on Cognitive Function in Alzheimer's
Disease. Archives of Neurology. 1998;55: pp. 1409-1415.
Sano M, Bell K, Cote L, et al. Double-blind Parallel Design
Pilot Study of Acetyl Levocarnitine in Patients with Alzheimer's Disease. Archives of Neurology.
1992;49: pp. 1137-1141.
Sano M, Ernesto C, Thomas RG, et al. A Controlled
Trial of Selegiline, Alpha-tocopherol, or Both
as Treatment for Alzheimer's Disease. The Alzheimer's
Disease Cooperative Study. New England Journal
of Medicine. 1997;336(17): pp. 1216-1222.
Thal LJ, Calvani M, Amato A, et al. A 1-year
Controlled Trial of Acetyl-L-Carnitine in Early-onset
AD. Neurology. 2000;55: pp. 805-810.
Books:
Last updated 10/23/02. Please send comments, questions,
and reports of problems to orcamind@ohsu.edu.
|
 |
|
